United States · Bill · HR
H.R. 254 (117th)
Neuromyelitis Optica Spectrum Disorder Consortium Act
Introduced
11 January 2021
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
Neuromyelitis Optica Spectrum Disorder Consortium Act This bill requires the National Institutes of Health to establish a national consortium to coordinate and support research on neuromyelitis optica spectrum disorder, including by awarding grants. This is a neurological disease that can cause blindness, paralysis, and premature death.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 11 January 2021
Introduced in House (PDF)
Introduced in House · EN · 11 January 2021
Introduced in House
summary · EN · 11 January 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/254
- Open data entity: https://api.congress.gov/v3/bill/117/hr/254